RhoA/Rho-Kinase: Pathophysiologic and Therapeutic Implications in Gastrointestinal Smooth Muscle Tone and Relaxation

Gastroenterology

Volumn 138, Issue 1, 2010, Pages

  Rattan, Satish ^a   Phillips, Benjamin R ^a   Maxwell IV, Pinckney J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; DIMETHYLALLYLTRANSFERASE; ENZYME INHIBITOR; FASUDIL; GGTI 297; GSK 269962A; H 1152; HA 1100; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SB 772077B; SLX 2119; SR 3677; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHOSPHORYLATION; COLON; ENZYME ACTIVATION; ENZYME ACTIVITY; ESOPHAGUS; GALLBLADDER; GASTROINTESTINAL MOTILITY DISORDER; HUMAN; MUSCLE FUNCTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PRENYLATION; SIGNAL TRANSDUCTION; SMALL INTESTINE; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE RELAXATION; SMOOTH MUSCLE TONE; STOMACH; UPREGULATION;

EID: 72249091852     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.11.016     Document Type: Article

References (121)

1. Murthy KS. Signaling for contraction and relaxation in smooth muscle of the gut. Annu Rev Physiol 2006;68:345-374.
2. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, Rhokinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol (Lond ) 2000;522:177-185.
3. Gerthoffer WT. Signal-transduction pathways that regulate visceral smooth muscle function III. Coupling of muscarinic receptors to signaling kinases and effector proteins in gastrointestinal smooth muscles. Am J Physiol Gastrointest Liver Physiol 2005;288: G849-G853.
4. Shimokawa H, Rashid M. Development of Rho-kinase inhibitors for cardiovascular medicine. Trends Pharmacol Sci 2007;28:296-302.
5. Jin L, Burnett AL. RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights. Clin Sci 2006;110: 153-165.
6. Oka M, Fagan KA, McMurtry IF. Therapeutic potential of RhoA/ Rho-kinase inhibitors in pulmonary hypertension. Br J Pharmacol 2009;155:444-454.
7. Canda AE, Cinar MG, Turna B, et al. Pharmacologic targets on the female urethra. Urol Int 2008;80:341-354.
8. Christ GJ, Andersson KE. Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract. Neurourol Urodyn 2007;26: 948-954.
9. Cook IJ, Brookes SJ. Colonic motor and sensory function and dysfunction. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and liver disease: pathophysiology/diagnosis/management. 8th ed. Philadelphia: Saunders/Elsevier; 2006:2111-2125.
10. Clouse RE, Diamant NE. Esophageal motor and sensory function and motor disorders of the esophagus. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Sleisenger & Fordtan's gastrointestinal and liver disease: pathophysiology/diagnosis/ management. 8th ed. Philadelphia: W.B. Saunders Company; 2006:855-904.
11. Farre R, Sifrim D. Regulation of basal tone, relaxation, and contraction of the lower esophageal sphincter. Relevance to drug discovery for esophageal disorders. Br J Pharmacol 2008; 153:858-869.
12. Rattan S. The internal anal sphincter: regulation of smooth muscle tone and relaxation. Neurogastroenterol Motil 2005;17: 50-59.
13. Sims SM, Chrones T, Preiksaitis HG. Calcium sensitization in human esophageal muscle: role for RhoA kinase in maintenance of lower esophageal sphincter tone. J Pharmacol Exp Ther 2008;327:178-186.
14. Rattan S, De Godoy MAF, Patel CA. Rho kinase as a novel molecular therapeutic target for hypertensive internal anal sphincter. Gastroenterology 2006;131:108-116.
15. Patel CA, Rattan S. Spontaneously tonic smooth muscle has characteristically higher levels of RhoA/ROK compared with the phasic smooth muscle. Am J Physiol Gastrointest Liver Physiol 2006;291:G830-G837.
16. Patel CA, Rattan S. Cellular regulation of basal tone in internal anal sphincter smooth muscle by RhoA/ROCK. Am J Physiol Gastrointest Liver Physiol 2007;292:G1747-G1756.
17. Madalinski M, Kalinowski L. Novel options for the pharmacological treatment of chronic anal fissure-Role of botulinum toxin. Curr Clin Pharmacol 2009;4:47-52.
18. Furness JB, Young HM, Pompolo S, et al. Plurichemical transmission and chemical coding of neurons in the digestive tract. Gastroenterology 1995;108:554-563.
19. Bornstein JC, Costa M, Grider JR. Enteric motor and interneuronal circuits controlling motility. Neurogastroenterol Motil 2004; 16:34-38.
20. De Godoy MAF, Rattan S. Autocrine regulation of internal anal sphincter tone by renin-angiotensin system: comparison with phasic smooth muscle. Am J Physiol Gastrointest Liver Physiol 2005;289:G1164-G1175.
21. Casselbrant C, Edebo A, Wennerblom J, et al. Actions by angiotensin II on esophageal contractility in humans. Gastroenterology 2007;132:249-260.
22. Cong P, Xiao ZL, Biancani P, et al. Prostaglandins mediate tonic contraction of the guinea pig and human gallbladder. Am J Physiol Gastrointest Liver Physiol 2008;292:G409-G418.
23. De Godoy MAF, Rattan N, Rattan S. COX-1 vs. COX-2 as a determinant of the basal tone in the internal anal sphincter. Am J Physiol Gastrointest Liver Physiol 2009;296:G219-G225.
24. Cao W, Harnett KM, Behar J, et al. PGF2+-induced contraction of cat esophageal and lower esophageal sphincter circular smooth muscle. Am J Physiol Gastrointest Liver Physiol 2002;283: G282-G291.
25. Izzo AA, Mascolo N, Capasso F. The gastrointestinal pharmacology of cannabinoids. Curr Opin Pharmacol 2001;1:597-603.
26. Spiegel S, Milstien S. Exogenous and intracellularly generated sphingosine 1-phosphate can regulate cellular processes by divergent pathways. Biochem Soc Trans 2003;31:1216-1219.
27. Boureux A, Vignal E, Faure S, et al. Evolution of the Rho Family of Ras-like GTPases in eukaryotes. Mol Biol Evol 2007;24:203-216.
28. Sanders KM. Regulation of smooth muscle excitation and contraction. Neurogastroenterol Motil 2008;20(Suppl 1):39-53.
29. Leung T, Chen XQ, Manser E, et al. The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol 2007; 16:5313-5327.
30. Reid T, Furuyashiki T, Ishizaki T, et al. Rhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the Rho-binding domain. J Biol Chem 1996;271:13556-13560.
31. Watanabe G, Saito Y, Madaule P, et al. Protein kinase N (PKN) and PKN-related protein rhophilin as targets of small GTPase Rho. Science 1996;271:645-648.
32. Ellenbrock SIJ, Collard JG. Rho GTPases: functions and association with cancer. Clin Exp Metastasis 2007;24:657-672.
33. Hart MJ, Jiang X, Kozasa T, et al. Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by G-13. Science 1998;280:2112-2114.
34. Murthy KS, Zhou H, Grider JR, et al. Differential signalling by muscarinic receptors in smooth muscle: m2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/Rac1 and p21-activated kinase 1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain myosin II) phosphorylation via Rhoassociated kinase/myosin phosphatase targeting subunit and protein kinase C/CPI-17 pathway. Biochem J 2003;374:145-155.
35. Vetter IR, Wittinghofer A. The guanine nucleotide-binding switch in three dimensions. Science 2001;294:1299-1304.
36. Gong MC, Iizuka K, Nixon G, et al. Role of guanine nucleotidebinding proteins ras-family or trimeric proteins or both in Ca2+ sensitization of smooth muscle. Proc Natl Acad Sci U S A 1996;93:1340-1345.
37. Gong MC, Fujihara H, Somlyo AV, et al. Translocation of rhoA associated with Ca2- sensitization of rabbit smooth muscle. J Biol Chem 1997;272:10704-10709.
38. Fujihara H, Walker LA, Gong MC, et al. Inhibition of RhoA translocation and calcium sensitization by in vivo ADP-ribosylation with the chimeric toxin DC3B. Mol Biol Cell 1997;8:2437-2447.
39. Chen XQ, Tan I, Ng CH, et al. Characterization of RhoA-binding kinase ROK- implication of the plecktrin homology domain in ROK- function using region-specific antibodies. J Biol Chem 2002;277: 12680-12688.
40. Yoshii A, Iizuka K, Dobashi K, et al. Relaxation of contracted rabbit tracheal and human bronchial smooth muscle by Y-27632 through inhibition of Ca2+ sensitization. Am J Respir Cell Mol Biol 1999;20:1190-1200.
41. Wang Y, Zheng XR, Riddick N, et al. ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells. Circ Res 2009;104:531-540.
42. Riddick N, Ohtani K, Surks HK. Targeting by myosin phosphatase- RhoA interacting protein mediates RhoA/ROCK regulation of myosin phosphatase. J Cell Biochem 2008;103:1158-1170.
43. Mizuno Y, Isotani E, Huang J, et al. Myosin light chain kinase activation and calcium sensitization in smooth muscle in vivo. Am J Physiol Cell Physiol 2008;295:C358-C364.
44. Berridge MJ. Smooth muscle cell calcium activation mechanisms. J Physiol 2008;586:5047-5061.
45. Hartshorne DJ, Ito M, Erdodi F. Role of protein phosphatase type 1 in contractile functions: myosin phosphatase. J Biol Chem 2004;279:37211-37214.
46. Kim HR, Appel S, Vetterkind S, et al. Smooth muscle signalling pathways in health and disease. J Cell Mol Med 2008;12: 2165-2180.
47. Matsumura F, Hartshorne DJ. Myosin phosphatase target subunit: many roles in cell function. Biochem Biophys Res Commun 2008;369:149-156.
48. Feng J, Ito M, Kureishi Y, et al. Rho-associated kinase of chicken gizzard smooth muscle. J Biol Chem 1999;274:3744-3752.
49. Hartshorne DJ, Ito M, Erdodi F. Myosin light chain phosphatase: subunit composition, interactions and regulation. J Muscle Res Cell Motil 1998;19:325-341.
50. Koyama M, Ito M, Feng J, et al. Phosphorylation of CPI-17, and inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase. FEBS Lett 2000;475:197-200.
51. Kitazawa T, Eto M, Woodsome TP, et al. Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J Biol Chem 2000;275:9897-9900.
52. Amano M, Ito M, Kimura K, et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 1996;271:20246-20249.
53. Kureishi Y, Kobayashi S, Amano M, et al. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem 1997;272:12257-12260.
54. Huang J, Zhou H, Mahavadi S, et al. Signaling pathways mediating gastrointestinal smooth muscle contraction and MLC20 phosphorylation by motilin receptors. Am J Physiol Gastrointest Liver Physiol 2005;288:G23-G31.
55. Harnett KM, Cao W, Biancani P. Signal-transduction pathways that regulate smooth muscle function I. Signal transduction in phasic (esophageal) and tonic (gastroesophageal sphincter) smooth muscles. Am J Physiol Gastrointest Liver Physiol 2005; 288:G407-G416.
56. Chitaley K, Webb RC. Nitric oxide induces dilation of rat aorta via inhibition of rho-kinase signaling. Hypertension 2002;39:438-442.
57. Bolz SS, Vogel L, Sollinger D, et al. Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway. Circulation 2003;107:3081-3087.
58. Golenhofen K, Mandrek K. Phasic and tonic contraction processes in the gastrointestinal tract. Dig Dis Sci 1991;9:341-346.
59. Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003;83:1325-1358.
60. Bitar KN, Ibitayo A, Patil SB. HSP27 modulates agonist-induced association of translocated RhoA and PKC-alpha in muscle cells of the colon. J Appl Physiol 2002;92:41-49.
61. Bitar KN. Function of gastrointestinal smooth muscle: from signaling to contractile proteins. Am J Med 2003;115:15S- 23S.
62. Eto M, Wong L, Yazawa M, et al. Inhibition of myosin/moesin phosphatase by expression of the phosphoinhibitor protein CPI-17 alters microfilament organization and retards cell spreading. Cell Motil Cytoskeleton 2000;46:222-234.
63. Woodsome TP, Eto M, Everett A, et al. Expression of CPI-17 and myosin phosphatase correlates with Ca2+ sensitivity of protein kinase C-induced contraction of rabbit smooth muscle. J Physiol (Lond) 2001;535:553-564.
64. De Godoy MAF, Dunn SR, Rattan S. Evidence for the role of angiotensin II biosynthesis in the rat internal anal sphincter tone. Gastroenterology 2004;127:127-138.
65. De Godoy MAF, Rattan N, Rattan S. Arachidonic acid metabolites follow the preferential course of cyclooxygenase pathway for the basal tone in the internal anal sphincter. Am J Physiol Gastrointest Liver Physiol 2009;296:G727-G734.
66. De Godoy MAF, Rattan S. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats. J Pharmacol Exp Ther 2006;318:725-734.
67. Khaikin M, Yebara S, Bashankaev B. Topical captopril cream: A new treatment for anal fissure? The first human study. Dis Colon Rectum 2007;50:747.
68. Olson MF. Applications for ROCK kinase inhibition. Curr Opin Cell Biol 2008;20:242-248.
69. Feng Y, Yin Y, Weiser A, et al. Discovery of substituted 4-(pyrazol- 4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors. J Med Chem 2008;51:6642-6645.
70. Ishizaki T, Uehata M, Tamechika I, et al. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 2000;57:976-983.
71. Eto M, Kitazawa T, Yazawa A, et al. Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms. J Biol Chem 2001;276:29072-29078.
72. Rattan S, Patel CA. Selectivity of Rho Kinase inhibitors in the spontaneously tonic smooth muscle. Am J Physiol Gastrointest Liver Physiol 2008;294:G687-G693.
73. Kim N, Cao W, Sang IS, et al. Distinct kinases are involved in contraction of cat esophageal and lower esophageal sphincter smooth muscles. Am J Physiol Cell Physiol 2004;287:C384-C394.
74. Park SY, Song HJ, Sohn UD. Participation of Rho-associated kinase in electrical stimulated and acetylcholine-induced contraction of feline esophageal smooth muscle. Eur J Pharmacol 2009;607:220-225.
75. Rattan S, Fan Y-P, Puri RN. Comparison of angiotensin II (Ang II) effects in the internal anal sphincter (IAS) and lower esophageal sphincter smooth muscles. Life Sci 2002;70:2147-2164.
76. Oishi K, Itoh Y, Isshiki Y, et al. Agonist-induced isometric contraction of smooth muscle cell-populated collagen gel fiber. Am J Physiol Cell Physiol 2000;279:C1432-C1442.
77. Ratz PH, Meehl JT, Eddinger TJ. RhoA kinase and protein kinase C participate in regulation of rabbit stomach fundus smooth muscle contraction. Br J Pharmacol 2002;137:983-992.
78. Sriwai W, Zhou H, Murthy KS. Gq-dependent signalling by the lysophosphatidic acid receptor LPA3 in gastric smooth muscle: reciprocal regulation of MYPT1 phosphorylation by Rho kinase and cAMP-independent PKA. Biochem J 2008;411:543-551.
79. Büyükafsar K, Levent A. Involvement of Rho/Rho-kinase signalling in the contractile activity and acetylcholine release in the mouse gastric fundus. Biochem Biophys Res Commun 2003; 303:777-781.
80. Dhaese I, Lefebvre RA. Myosin light chain phosphatase activation is involved in the hydrogen sulfide-induced relaxation in mouse gastric fundus. Eur J Pharmacol 2009;606:180-186.
81. Mustafa S, Oriowo MA. Cooling-induced contraction of the rat gastric fundus: mediation via transient receptor potential (TRP) cation channel TRPM8 receptor and rho-kinase activation. Clin Exp Pharmacol Physiol 2005;32:832-838.
82. Tomomassa T, Takahashi A, Kaneko H, et al. Y-27632 inhibits gastric motility in conscious rats. Life Sci 2000;66:29-34.
83. Behar J, Corazziari E, Guelrud M, et al. Functional gallbladder and sphincter of Oddi disorders. Gastroenterology 2006;130: 1498-1509.
84. Buyukafsar K, Akca T, Tiftik RN, et al. Contribution of Rho-kinase in human gallbladder contractions. Eur J Pharmacol 2006;540: 162-167.
85. Quinn T, Feighery R, Baird AW. Role of Rho-kinase in guinea-pig gallbladder smooth muscle contraction. Eur J Pharmacol 2006; 534:210-217.
86. Camello-Almaraz C, Maclas B, Gomez-Pinilla PJ, et al. Developmental changes in Ca2+ homeostasis and contractility in gallbladder smooth muscle. Am J Physiol Cell Physiol 2009;296: C783-C791.
87. Sahan-Firat S, Tiftik RN, Nacak M, et al. Rho kinase expression and its central role in ovine gallbladder contractions elicited by variety of excitatory stimuli. Eur J Pharmacol 2005;528:169-175.
88. Jones MP, Bratten JR. Small intestinal motility. Curr Opin Gastroenterol 2008;24:164-172.
89. Kuemmerle JF. Motility disorders of the small intestine: new insights into old problems. J Clin Gastroenterol 2000;31:276-281.
90. Sward K, Dreja K, Susnjar M, et al. Inhibition of Rho-associated kinase blocks agonist-induced Ca2+ sensitization of myosin phosphorylation and force in guinea-pig ileum. J Physiol (Lond) 2000;522:33-49.
91. Mori M, Tsushima H. Vanadate activates Rho A translocation in association with contracting effects in ileal longitudinal smooth muscle of guinea pig. J Pharmacol Sci 2004;95:443-451.
92. Mori M, Tsushima H. Activation of Rho signaling contributes to lysophosphatidic acid-induced contraction of intact ileal smooth muscle of guinea-pig. Can J Physiol Pharmacol 2000;78:729-736.
93. Otto B, Steusloff A, Just I, et al. Role of rho proteins in carbachol- induced contractions in intact and permeabilized guinea-pig intestinal smooth muscle. J Physiol (Lond) 1996;496:317-329.
94. Borman MA, MacDonald JA, Haystead TA. Staurosporine inhibition of zipper-interacting protein kinase contractile effects in gastrointestinal smooth muscle. Biochem Cell Biol 2007;85: 111-120.
95. Ihara E, Moffat L, Ostrander J, et al. Characterization of protein kinase pathways responsible for Ca2+ sensitization in rat ileal longitudinal smooth muscle. Am J Physiol Gastrointest Liver Physiol 2007;293:G699-G710.
96. Hersch E, Huang J, Grider JR, et al. Gq/G13 signaling by ET-1 in smooth muscle: MYPT1 phosphorylation via ETA and CPI-17 dephosphorylation via ETB. Am J Physiol Cell Physiol 2004;287: C1209-C1218.
97. Loirand G, Cario-Taumaniantz C, Chardin P, et al. The rho-related protein Rnd1 inhibits Ca2+ sensitization of rat smooth muscle. J Physiol 1999;516:825-834.
98. González-Montelongo MC. Androgen differentially potentiate mouse intestinal smooth muscle by nongenomic activation of polyamine synthesis and rho kinase activation . Endocrinology 2006;147:5715-5729.
99. Patil SB, Tsunoda Y, Pawar MD, et al. Translocation and association of ROCK-II with RhoA and HSP27 during contraction of rabbit colon smooth muscle cells. Biochem Biophys Res Commun 2004;319:95-102.
100. Patil SB, Bitar KN. RhoA- and PKC-mediated phosphorylation of MYPT and its association with HSP27 in colonic smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 2006;290: G83-G95.
101. Takeuchi T, Kushida M, Hirayama N, et al. Mechanisms involved in carbachol-induced Ca2+ sensitization of contractile elements in rat proximal and distal colon. Br J Pharmacol 2004;142:657-666.
102. Takeuchi T, Nakajima H, Hata F, et al. A minor role for Ca2+ sensitization in sustained contraction through activation of muscarinic receptor in circular muscle of rat colon. Pflugers Arch 2007;454:565-574.
103. Bitar KN, Hillemeier C, Biancani P, et al. Regulation of smooth muscle contraction in rabbit internal anal sphincter by protein kinase C and Ins(1, 4, 5)P3. Am J Physiol Gastrointest Liver Physiol 1991;260:G537-G542.
104. Bitar KN, Hillemeier C, Biancani P. Differential regulation of smooth muscle contraction in rabbit internal anal sphincter by substance P and bombesin. Life Sci 1990;47:2429-2434.
105. Somara S, Gilmont RR, Dennis RG, et al. Bioengineered internal anal sphincter derived from isolated human internal anal sphincter smooth muscle cells. Gastroenterology 2009;137: 53-61.
106. Okano M, Uchikawa Y, Tanaka N, et al. Rho-kinase, but not protein kinase C, is involved in generation of the spontaneous tone in the resting phase of the isolated pig iris sphincter muscle. Curr Eye Res 2009;34:177-183.
107. Walters CE, Pryce G, Hankey DJR, et al. Inhibition of Rho GTPases with protein prenyltransferase inhibitors prevents leukocyte recruitment to the central nervous system and attenuates clinical signs of disease in an animal model of multiple sclerosis. J Immunol 2002;168:4087-4094.
108. Katayama M, Kawata M, Yoshida Y, et al. The posttranslationally modified C-terminal structure of bovine aortic smooth muscle rhoA p21. J Biol Chem 1991;266:12639-12645.
109. Berzat AC, Brady DC, Fiordalisi JJ, et al. Using inhibitors of prenylation to block localization and transforming activity. Methods Enzymol 2006;407:575-597.
110. Patel CA, Rattan S. RhoA prenylation inhibitor produces relaxation of tonic smooth muscle of internal anal sphincter. J Pharmacol Exp Ther 2007;321:501-508.
111. Li M, Li Z, Sun X. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells. Eur J Pharmacol 2008;591:219-223.
112. Chiba Y, Arima J, Sakai H, et al. Lovastatin inhibits bronchial hyperresponsiveness by reducing RhoA signaling in rat allergic asthma. Am J Physiol Lung Cell Mol Physiol 2009;294:L705-L713.
113. Larson SD, Jackson LN, Chen LA, et al. Effectiveness of siRNA uptake in target tissues by various delivery methods. Surgery 2007;142:262-269.
114. Pasricha PJ. Treatment of disorders of bowel motility and water flux; antiemetics; agents used in biliary and pancreatic disease. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006:983-1008.
115. Dressler D, Saberi AF. Botulinum toxin: mechanisms of action. Eur Neurol 2005;53:3-9.
116. Singh BR. Molecular basis of the unique endopeptidase activity of botulinum neurotoxin. In: Brin MF, Hallet M, Jankovic J, eds. Scientific and therapeutic aspects of botulinum toxin. Philadelphia: Lippincott Williams & Wilkins; 2002:75-88.
117. Munchau A, Bhalla KP. Uses of botulinum toxin injection in medicine today. Br Med J 2000;320:161-165.
118. Aktories K, Just I. In vitro ADP-ribosylation of Rho by bacterial ADP-ribosyltransferases. Methods Enzymol 1995;256:184-195.
119. Aktories K. Bacterial toxins that target Rho proteins. J Clin Invest 1997;99:827-829.
120. Sekine A, Fujiwara M, Narumiya S. Asparagine residue in the rho gene product is the modification site for botulinum ADP-ribosyltransferase. J Biol Chem 1989;264:8602-8605.
121. Ishida H, Zhang X, Erickson K, et al. Botulinum toxin type A targets RhoB to inhibit lysophosphatidic acid-stimulated actin reorganization and acetylcholine release in nerve growth factortreated PC12 cells. J Pharmacol Exp Ther 2004;310:881-889.